Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PT-141

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
INTRODUCTION Melanocortins affect multiple physiological responses, including sexual behaviors. Bremelanotide is a synthetic… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2005
2005
OBJECTIVES To evaluate the safety and pharmacodynamic effect of co-administration of subtherapeutic doses of PT-141, a cyclic… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following intranasal administration in healthy male subjects and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PT-141, a cyclic heptapeptide melanocortin analog, was evaluated following subcutaneous administration to healthy male subjects… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Disorders of sexual desire affect an estimated 30% of women in North America and Europe, with etiologies based on interpersonal… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2004
2004
  • S. Frantz
  • Nature Reviews Drug Discovery
  • 2004
  • Corpus ID: 7107118
The considerable success of phosphodiesterase 5 inhibitors, such as sildenafil (Viagra; Pfizer), in the treatment of erectile… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Abstract: PT‐141, a synthetic peptide analogue of α‐MSH, is an agonist at melanocortin receptors including the MC3R and MC4R… Expand
Is this relevant?